Treatment of intracranial tumors by systemic transfer of superantigen- activated tumor-draining lymph node T cells

Cancer Research

Volumn 56, Issue 20, 1996, Pages 4702-4708

  Inoue, Mamoru ^a   Plautz, Gregory E ^a   Shu, Suyu ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER IMMUNOTHERAPY; FEMALE; INTRACRANIAL TUMOR; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME;

ANIMALS; BRAIN NEOPLASMS; CARCINOGENS; CD4-CD8 RATIO; CROSS REACTIONS; FEMALE; FIBROSARCOMA; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; METHYLCHOLANTHRENE; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; SUPERANTIGENS; T-LYMPHOCYTE SUBSETS; WHOLE-BODY IRRADIATION;

EID: 0029840436     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. DeVries, J. E., and Spits, H. Cloned human cytotoxic lymphocyte lines reactive with autologous melanoma cells J. Immunol., 132 510-519, 1983.
2. Mukherji, B., and MacAlister, T. J Clonal analysis of cytotoxic T cell response against human melanomas. J. Exp. Med., 158: 240-245, 1983.
3. Anichini, A., Mazzocchi, A., Fossati, G , and Parmiani, G. Cytolytic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells J. Immunol, 142: 3692-3701, 1989
4. Knuth, A., Wolfel, T., Klehmann, E., Boon, T , and Meyer Zum Buschenfelde, K. H. Cytolytic T-cell clones against an autologous human melanoma specific study and definition of three antigens by immunoselection Proc. Natl. Acad. Sci USA, 86: 2804-2808, 1989.
5. Cozzolino, F., Torcia, M , Carossino, A., Giordani, R., Selli, C , Talini, G., Realli, E., Novelli, A., Pistoia, V., and Ferranni, M. Characterization of cells from invaded lymph nodes in patients with solid tumors. J Exp. Med., 166: 303-318, 1987.
6. Barnd, D., Kerr, L., Metzgar, R., and Finn, O. Human tumor-specific T cell lines generated from invaded lymph nodes in patients with solid tumors Transplant. Proc., 20. 339-341, 1988
7. Mukherji, B., Guha, A , Chakrebarty, N., Sivandham, M., Nafhed, A., Sporn, J , and Ergin, M. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma J. Exp Med., 169: 1961-1967, 1989
8. Whiteside, T L , Miescher, S , Hulimann, J., Moretta, L., and Von Hiedner, U. Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas. Cancer Immunol Immunother., 23. 169-178, 1986.
9. Muul, L. M., Spiess, P J , Director, E. P., and Rosenberg, S. A. Identification of specific cytolytic immune response against autologous tumor in humans bearing malignant melanoma J Immunol., 138: 989-995, 1987
10. Topalian, S. L , Soloman, D., and Rosenberg, S A Tumor-specific cytotysis by lymphocytes infiltrating human melanomas J. Immunol , 142: 3714-3725, 1989.
11. Shu, S , Chou, T , and Rosenberg, S. A Generation from tumor-bearing mice of lymphocytes with in vitro therapeutic efficacy J Immunol , 139: 295-304, 1987.
12. Yoshizawa, H., Chang, A. E , and Shu, S. Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2. J. Immunol. 147: 729-737, 1991
13. Grassland, K D., Lee, V K., Chen, W., Riddell, S. R , Greenberg, P. D., and Cheever, M. A T cells from tumor-immune mice nonspecifically expanded in vitro with anti-CD3 plus IL-2 retain specific function in vitro and can eradicate disseminated leukemia in vitro. J. Immunol., 146: 4414-4420, 1991
14. Shu, S , Krinock, R. A , Matsumura, T , Sussman, J J., Fox, B A., Chang, A. E., and Terman, D. S. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells J. Immunol., 152: 1277-1288, 1994.
15. Marrack, P , and Kappler, J. The staphylococcal enterotoxins and their relatives Science (Washington DC), 248 705-711, 1990.
16. Fontana, A., and Fierz, W. The endothelium-astrocyte immune control system of the brain. Semin Immunopathol., 8: 57-70, 1985
17. Lampson, L A., and Hickey, W. F. Monoclonal antibody analysis of the MHC expression in human brain biopsies. J. Immunol., 136: 4054-4062, 1986.
18. Mitchell, M. S. Relapse in the central nervous system in melanoma patients successfully treated with biomodulators. J. Clin. Oncol., 7: 1701-1709, 1989.
19. Di Lorenzo, N , Palma, L., and Nicole, S. Lymphocytic infiltration in long-survival glioblastomas: possible host's resistance. Acta Neurochir., 39: 27-33, 1977.
20. Palma, L., Di Lorenzo, N., and Guidetti, B. Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate and relevance to prognosis in 228 operated cases. J. Neurosurg., 49: 854-861, 1978
21. Sawamura, Y., and de Tribolet, N. Immunotherapy of brain tumors. J. Neurosurg Sci., 34: 265-278, 1990.
22. Lillihei, K O., Mitchell, D. H , Johnson, S. D., McCleary, E. L., and Kruse, C. A. Long-term follow-up of patients with recurrent malignant gliomas treated with adjuvant adoptive immunotherapy. Neurosurgery, 28: 16-23, 1991.
23. Medawar, P. W. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye Br. J. Exp. Pathol., 29: 58-69, 1948.
24. Takai, N., Tanaka, R., Yoshida, S., Hara, N , and Saito, T. In Vivo and in Vitro effect of adoptive immunotherapy of experimental murine brain tumors using lymphokine-activated killer cells. Cancer Res., 48. 2047-2052, 1988
25. Staib, L., Harel, W., and Mitchell, M. S. Protection against experimental cerebral metastases of murine melanoma B16 by active immunization Cancer Res., 53: 1113-1121, 1993.
26. Raine, C. S. Biology of disease. The analysis of autoimmune demyelination its impact upon multiple sclerosis. Lab Invest., 50: 608-635, 1984
27. Hafler, D. A., and Weiner, H L T cells in multiple sclerosis and inflammatory central nervous system disease. Immunol. Rev., 100: 307-332, 1987.
28. Matsumura, T., Sussman, J. J., Krinock, R. A., Chang, A E, and Shu, S. Characteristics and in Vivo homing of long-term T-cell lines and clones derived from tumor-draining lymph nodes. Cancer Res., 54: 2744-2750, 1994.
29. Wahl, W. L., Sussman, J. J , Shu, S., and Chang, A. E Adoptive immunotherapy of murine intracerebral tumors with anti-CD3/interleukin-2-activated tumor-draining lymph node cells. J. Immunother., 15: 242-250, 1994.
30. Sussman, J. J , Wahl, W. L., Chang, A E., and Shu, S Unique characteristics associated with systemic adoptive immunotherapy of experimental intracerebral tumors. J Immunother, 18: 35-44, 1995.
31. Feltkamp, M. C W , Smits, H. L., Vierboom, M. P. M., Minnaar, R. P , de Jongh, B. M., Drijfhout, J. W., ter Schegget, J , Melief, C. J. M , and Kast, W. M. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol., 23: 2242-2249, 1993.
32. Irvine, K. R., McCabe, B. J , Rosenberg, S. A., and Restifo, N. P. Synthetic oligonucleotide expressed by a recombinant vaccinia virus elicits therapeutic CTL J. Immunol., 154: 4651-4657, 1995.
33. Mukherji, B., Chakraborty, N. G , Yamasaki, S., Okino, T., Yamase, H , Sporn, J. R , Kurtzman, S. K., Ergin, M. T., Ozols, J., Meehan, J., and Mauri, F. Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells Proc Natl. Acad Sci. USA, 92: 8078-8082, 1995.
34. Barth, R. J , Jr., Bock, S N., Mule, J. J., and Rosenberg, S. A. Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes. J Immunol., 144 1531-1537, 1990.
35. Leo, O , Foo, M , Sachs, D. H., Samelson, L. E., and Bluestone, J. A. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl. Acad. Sci. USA, 84. 1374-1378, 1987
36. Pullen, A M., Marrack, P., and Kappler, J. W The T cell repertoire is heavily influenced by tolerance to polymorphic self-antigens. Nature (Lond.), 335: 796-801, 1988
37. Reich, E. P., Sherwin, R S , Kanagawa, O., and Janeway, C. A. J. An explanation for the protective effect of MHC class II I-E molecule in murine diabetes. Nature (Lond.), 341: 326-328, 1989.
38. Bill, J., Kanagawa, O., Woodland, D L , and Palmer, E. The MHC molecule I-E is necessary but not sufficient for the clonal deletion of Vβ11-bearing T cells J. Exp Med., 169: 1405-1419, 1989
39. Staerz, U , Rammansee, H., Benedetto, J., and Bevan, M Characterization of a murine monoclonal antibody specific for an allotype determinant on T cell antigen receptor J. Immunol., 134: 3994-4000, 1985.
40. Nitta, T., Oksenberg, J. R., Rao, N A., and Steinman, L. Prodominant expression of T cell receptor Vα7 in tumor-infiltrating lymphocytes in uveal melanoma Science (Washington DC), 249: 672-674, 1990
41. Weidman, E., Whiteside, T L., Giorda, R , Herberman, R. B., and Truco, M. The T-cell receptor Vβ gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma. Cancer Res., 52: 5913-5920, 1992.
42. Ikeda, H , Sato, N., Matsunnra, A , and Kikuchi, K Analysis of T-cell receptor V region usage of cytotoxic T lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinoma. Cancer Res., 53: 3078-3084, 1993.
43. thor Straten, P , Scholler, J., Hou-Jensen, K., and Zeuthen, J. Preferential usage of T-cell receptor αβ variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas. Int. J Cancer, 56: 78-86, 1994
44. Brichard, V , Van Pel, A , Wolfel, T., Wolfel, C., De Plaen, E , Lethe, B., Coulie, P., and Boon, T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp Med , 178: 489-495, 1993.
45. Bakker, A. B , Schreurs, M. W., de Boer, A J., Kawakami, Y., Rosenberg, S. A., Adema, G. J., and Figdor, C. G. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp Med., 179. 1005-1009, 1994.
46. Kawakami, Y., Eliyahu, S., Delgado, C. H , Robbins, P. F , Sakaguchi, K , Appella, E , Yannelli, J. R., Adema, G. J , Miki, T., and Rosenberg, S. A. Identification of a human melanoma antigen recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA, 91: 6458-6462, 1994.
47. Coulie, P. G , Brichard, V., Van Pel, A., Wolfel, T , Schneider, J , Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J., Renauld, J , and Boon, T. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 180: 35-42, 1994.
48. Kawakami, Y., Eliyahu, S., Delgado, C H., Robbins, P. F., Rivoltini, L., Topalian, S. L , Miki, T., and Rosenberg, S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T-cells infiltrating into tumor. Proc. Natl Acad. Sci. USA, 91: 3515-3519, 1994.
49. van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P G., Boel, P., De Smet, C , Traversari, C , Townsend, A., and Boon, T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytic T lymphocytes that recognize tumor cells expressing MACE-3 Eur. J. Immunol., 12. 3038-3044, 1994.
50. Darrow, T L., Slingluff, C. L., and Seigler, H F The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes, evidence for shared tumor antigens J Immunol. 142 3329-3335, 1989.
51. Salvi, S. Segalla, F., Rao, S , Arianti, F., Sartori, M., Bratina, G., Caronni, E., Anichini, A., Clemente, C., Parmiani, G , and Sensi, M. Overexpression of the T-cell receptor β-chain variable region TCRβV14 in HLA-A2-matched primary human melanoma Cancer Res., 55. 3374-3379, 1995
52. Ferradini, L , Raman-Roman, S., Azocar, J., Avril, M., Viel, S , Triebel, F., and Hercend, T Analysis of T-cell receptor α/β variability in lymphocytes infiltrating a melanoma metastasis Cancer Res., 52: 4649-4654, 1992
53. Mokyr, M B., Rubin, M , Newell, K. A., Prokhorova, A., and Bluestone, J. A. Involvement if TCR-Vβ8 3+ cells in the cure of mice bearing a large MOPC-315 tumor by low dose melphalan. J. Immunol , 151: 4838-4846, 1993.
54. Suzuki, M., Koseki, H , Mizutani, Y., Kunbayashi, K., Kanno, M., and Taniguchi, M. Expansion of murine T cells bearing a unique T cell receptor β-chain in Friend virus-induced tumor in situ J. Immunol , 148 2968-2974, 1992.
55. Karpati, R M., Banks, S. M , Malissan, B., Rosenberg, S. A., Sheard, M A., Weber, J S , and Hodes, R J Phenotypic characterization of murine tumor-infiltrating T lymphocytes. J. Immunol , 146: 2043-2051, 1991.
56. Dhein, J , Walczak, H., Baumier, C. Debatin, K , and Krammer, P. H. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature (Lond.), 373: 438-441, 1995.
57. Schwartz, R. H A cell culture model for T lymphocyte clonal anergy. Science (Washington DC), 248: 1349-1356, 1990.
58. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature (Lond.), 349: 245-248, 1991.
59. + antigen-presenting cells Int. Immunol , 4: 1381-1388, 1992.
60. Groux, H , Monte, D., Plouvier, B., Capron, A , and Ameisen, J-C, CD-3 mediated apoptosis of human medullary thymocytes and activated peripheral T cells respective roles of interleukin-1, interleukin-2, interferon-γ, and accessory cells. Eur. J. Immunol., 23 1623-1629, 1993
61. Plautz, G. E , Inoue, M., and Shu, S. Defining the synergistic effects of irradiation and T-cell immunotherapy for murine intracranial tumors Cell. Immunol., 171: 277-284, 1996.
62. Saris, S C., Rosenberg, S A , and Friedman, R B. Penetration of recombinant interleukin-2 across the blood-cerebrospinal fluid barrier J. Neurosurg , 69: 29-34, 1988.
63. Saris, S C , Patronas, N. J , Rosenberg, S A , Alexander, J. T., Frank, J., Schwartzentruber, D J., Rubin, J. T., Barba, D , and Oldfield, E H The effect of intravenous interleukin-2 on brain water content J. Neurosurg., 71. 169-174, 1989.